Recent

% | $
Quotes you view appear here for quick access.

Nymox Pharmaceutical Corporation Message Board

  • mox_police mox_police Apr 19, 2000 4:12 PM Flag

    Insider buying?

    Question:

    how many shares of nymx are
    owned by members of the Board of Directors (aside from
    Dr A)?

    The person with the right answer wins
    a
    free ad7c test - spinal tap version.

    Ha!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Novartis AG Gets FDA OK To Market Exelon
      Dow
      Jones Newswires
      EAST HANOVER, N.J. -- Novartis AG's
      (Z.NOV) Novartis Pharmaceuticals Corp. received Food and
      Drug Administration approval to market Exelon, a
      cholinesterase inhibitor for the treatment of patients with mild
      to moderate Alzheimer's disease.

      In a press
      release Friday, the company said Exelon is now cleared
      for marketing in nearly 70 countries.

      -Bill
      Platt; Dow Jones Newswires; 201-938-5400

      • 1 Reply to tansexygrl
      • The market potential for Alzheimer's diagnostics
        (screening and monitoring therapy) is estimated to be
        $6-800M in the US alone. Quite frankly, I didn't acquire
        this stock with the drug therapy in mind...rather to
        play the diagnostic products. Unless NYMX gets a BIG
        Pharma partner to develop any compound, they should
        stick to the diagnostic side. The Serex thing gives
        them a number of new and exciting options there. Hey,
        just one investors opinion...p.s. love your screen
        name.

 
NYMX
1.34+0.01(+0.75%)Jul 1 4:00 PMEDT